Abstract | BACKGROUND: MATERIAL/METHODS: RESULTS: Both PON1 paraoxonase and arylesterase were lower in the non-diabetic SCAD group, but VWF levels were higher (versus controls, all P<0.001). PON1 paraoxonase activity (OR=0.991), PON1 arylesterase activity (OR=0.981), and VWF (OR 2.854) influenced SCAD in multiple logistic regression. Decreased PON1 arylesterase activity and increased VWF levels were associated with severe atherosclerosis in non-diabetic SCAD patients. We also observed a slight negative correlation between VWF and PON1 paraoxonase/ arylesterase. CONCLUSIONS: PON1 and VWF are detectable markers that may predict the severity of stenoses, ideally facilitating a non-diabetic SCAD diagnosis before the sudden onset of life-threatening symptoms.
|
Authors | Jieying Ding, Qizhi Chen, Xing Zhuang, Zhilei Feng, Lili Xu, Fuxiang Chen |
Journal | Medical science monitor : international medical journal of experimental and clinical research
(Med Sci Monit)
Vol. 20
Pg. 2421-9
(Nov 25 2014)
ISSN: 1643-3750 [Electronic] United States |
PMID | 25420483
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- von Willebrand Factor
- Aryldialkylphosphatase
- PON1 protein, human
|
Topics |
- Aged
- Aryldialkylphosphatase
(blood)
- Case-Control Studies
- Coronary Artery Disease
(blood, complications, enzymology)
- Coronary Stenosis
(blood, complications)
- Diabetes Mellitus
(blood)
- Female
- Humans
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- ROC Curve
- Reproducibility of Results
- von Willebrand Factor
(metabolism)
|